At a glance
- Originator Eli Lilly and Company
- Class Neuroprotectants; Nootropics; Small molecules; Tetrazoles
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 18 Dec 1996 No-Development-Reported for Neurological disorders (Prevention) in United Kingdom (Unknown route)
- 18 Dec 1996 No-Development-Reported for Neurological disorders (Prevention) in USA (Unknown route)